Article
Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status.
PloS one - 1 Jan 2013
Planck Maria, Edlund Karolina, Botling Johan, Micke Patrick, Isaksson Sofi, Staaf Johan
Abstract excerpt
INTRODUCTION: In lung adenocarcinoma, the mutational spectrum is dominated by EGFR and KRAS mutations. Improved knowledge about genomic and transcriptional alterations in and between mutation-defined subgroups may identify genes involved in disease development or progression. METHODS: Genomic profiles from 457 adenocarcinomas, including 113 EGFR-mutated, 134 KRAS-mutated and 210 EGFR and KRAS-wild type tumors...
Topics
- Adenocarcinoma
- Adenocarcinoma of Lung
- DNA Copy Number Variations
- ErbB Receptors
- Female
- Genes, ras
- Genomics
- Humans
- Lung Neoplasms
- Male
- Mutation
